Jabil Inc vs Moderna, Inc. — how do they compare? Jabil Inc trades at $362.37 (market cap $37.37B), while Moderna, Inc. trades at $60.5 (market cap $24.18B). The key difference: Jabil Inc is the larger of the two by market cap, and Jabil Inc pays a 0.09% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| JBL | MRNA | |
|---|---|---|
Market Cap | $37.37B | $24.18B |
Sector | Technology | Health |
52-Week High | $385.50 | $81.80 |
52-Week Low | $192.49 | $22.36 |
Enterprise Value | $39.90B | $20.33B |
Dividend Yield | 0.09% | — |
Trailing returns across standard periods
Latest headlines on both assets
Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.
Read more on JBL →Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →